Clinical trials
Obesity trials in Turkey (Türkiye)
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
344 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2005 | 1 |
| 2006 | 2 |
| 2009 | 1 |
| 2011 | 5 |
| 2012 | 1 |
| 2013 | 4 |
| 2014 | 5 |
| 2015 | 2 |
| 2016 | 1 |
| 2017 | 11 |
| 2018 | 10 |
| 2019 | 23 |
| 2020 | 19 |
| 2021 | 22 |
| 2022 | 54 |
| 2023 | 38 |
| 2024 | 38 |
| 2025 | 52 |
| 2026 | 54 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 228 |
| Recruiting | 37 |
| Unknown status | 28 |
| Not yet recruiting | 27 |
| Active, not recruiting | 16 |
| Terminated | 3 |
| Withdrawn | 3 |
| Enrolling by invitation | 2 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Novo Nordisk A/S | 16 |
| Istanbul University | 10 |
| Marmara University | 9 |
| Medipol University | 8 |
| Ondokuz Mayıs University | 8 |
| Pamukkale University | 8 |
| Hacettepe University | 7 |
| Ataturk University | 6 |
| Ege University | 6 |
| Fatih Sultan Mehmet Training and Research Hospital | 6 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Obesity | 344 |
| Overweight | 86 |
| Weight Loss | 20 |
| Obesity, Morbid | 19 |
| Diabetes Mellitus, Type 2 | 14 |
| Diabetes Mellitus | 11 |
| Insulin Resistance | 11 |
| Pediatric Obesity | 11 |
| Polycystic Ovary Syndrome | 11 |
| Inflammation | 6 |
Trials
Showing 1 to 25 of 344. Each trial links to its page on Pharma Observatory.
244 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.